XIANGDONG XUE - nanomedicine - Best Researcher Award
Shanghai Jiao Tong University - China
AUTHOR PROFILE
🧬 EXPERT IN ENVIRONMENTAL SELF-ADAPTIVE NANOMEDICINE:
DR. XIANGDONG XUE is renowned for his pioneering work in environmental self-adaptive nanomedicine. His research focuses on developing advanced nanomedicines that adapt to environmental conditions, aiming to enhance the effectiveness of disease treatments and improve patient outcomes through innovative approaches in drug delivery and targeted therapy.
💉 SPECIALIST IN IMMUNOREGULATION AND IMMUNOTHERAPY:
DR. XUE's expertise extends to immunoregulation and immunotherapy. He is dedicated to exploring how nanomedicines can be utilized to modulate the immune system and enhance immunotherapy treatments, contributing to more effective and personalized cancer therapies.
📚 FIRST AND CORRESPONDING AUTHOR OF IMPACTFUL PUBLICATIONS:
DR. XUE has authored several high-impact publications as the first and corresponding author. His notable works include studies on manganese-coordinated nanoparticles, metal-coordination stabilized small-molecule nanomedicines, and transformative nanoplatforms for cancer treatment, published in top journals such as Biomaterials and Nano Letters.
🔬 DEVELOPER OF SYNERGISTIC THERAPIES:
DR. XUE's research is distinguished by the development of synergistic therapies combining phototherapy, immunotherapy, and chemotherapy. His work on drug-drug conjugates and multifunctional nanomedicines demonstrates his commitment to creating innovative solutions for complex cancer treatments and advancing the field of nanomedicine.
🌟 INNOVATOR IN NANOMEDICINE PLATFORMS:
DR. XUE has made significant contributions to the creation of transformative nanoplatforms with multiple therapeutic and immunostimulatory properties. His research includes developing nanomedicines with high drug-loading capacities and synergistic properties for advanced cancer treatment, reflecting his expertise in harnessing nanotechnology for medical breakthroughs.
🧪 LEADING RESEARCHER IN CANCER IMMUNOTHERAPIES:
DR. XUE’s contributions to the field of cancer immunotherapies are significant. His studies on nanotechnology-empowered combination therapies highlight his role in advancing cancer treatment through innovative nanomedicine strategies that integrate mechanisms of synergy and efficacy.
🌍 PROLIFIC RESEARCHER WITH GLOBAL IMPACT:
DR. XUE’s research has global implications, with publications addressing critical aspects of nanomedicine and cancer treatment. His work is recognized internationally for its impact on improving cancer therapies and advancing the field of nanomedicine through cutting-edge research and development.
NOTABLE PUBLICATION
Nanotechnology-Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
Authors: Pan, Y., Xue, X., Liang, X.-J.
Year: 2024
Journal: Advanced NanoBiomed Research
Biomimetic Lung-Targeting Nanoparticles with Antioxidative and Nrf2 Activating Properties for Treating Ischemia/Reperfusion-Induced Acute Lung Injury
Authors: Wang, Y., Dong, H., Qu, H., Xue, X., Hu, R.
Year: 2024
Journal: Nano Letters
Metal-Coordination Stabilized Small-Molecule Nanomedicine with High Drug-Loading Capacity and Synergistic Photochemotherapy for Cancer Treatment
Authors: Chen, H., Qu, H., Lu, B., Hu, R., Xue, X.
Year: 2024
Journal: Nanoscale
Charge-Reversible Crosslinked Nanoparticle for Pro-Apoptotic Peptide Delivery and Synergistic Photodynamic Cancer Therapy
Authors: Qu, H., Chen, H., Cheng, W., Liang, X.-J., Xue, X.
Year: 2023
Journal: Nano Research
Uncovering the Fate and Risks of Intravenously Injected Prussian Blue Nanoparticles in Mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics, and Metabolomics
Authors: Qu, H., Jin, X., Cheng, W., Xue, X., Wang, Y.
Year: 2023
Journal: Particle and Fibre Toxicology